How severe is CVE-2004-2092?

CVE-2004-2092 has a CVSS 2.0 base score of 4.6, rated medium severity.

Is CVE-2004-2092 being actively exploited?

It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (37th percentile), an estimate of the probability of exploitation in the next 30 days.

What products are affected by CVE-2004-2092?

CVE-2004-2092 affects Broadcom Inoculateit. See the affected-products list for the exact vulnerable versions.

How do I fix CVE-2004-2092?

Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.

When was CVE-2004-2092 published?

CVE-2004-2092 was published on 2004-02-09 and last updated on 2026-06-16.

CVE-2004-2092

CVE-2004-2092 is a medium-severity vulnerability in Broadcom Inoculateit with a CVSS 2.0 base score of 4.6. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low.

Key facts

Severity: Medium (CVSS 2.0 base score 4.6)
EPSS exploit prediction: 0% (37th percentile)
Actively exploited: Not listed in CISA KEV
Affected product: Broadcom Inoculateit
Published: 2004-02-09
Last modified: 2026-06-16

Description

eTrust InoculateIT for Linux 6.0 uses insecure permissions for multiple files and directories, including the application's registry and tmp directories, which allows local users to delete, modify, or examine sensitive information.

Frequently asked questions

What is CVE-2004-2092?: eTrust InoculateIT for Linux 6.0 uses insecure permissions for multiple files and directories, including the application's registry and tmp directories, which allows local users to delete, modify, or examine sensitive information.
How severe is CVE-2004-2092?: CVE-2004-2092 has a CVSS 2.0 base score of 4.6, rated medium severity.
Is CVE-2004-2092 being actively exploited?: It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (37th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2004-2092?: CVE-2004-2092 affects Broadcom Inoculateit. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2004-2092?: Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
When was CVE-2004-2092 published?: CVE-2004-2092 was published on 2004-02-09 and last updated on 2026-06-16.

References

Affected products (1)

cpe:2.3:a:broadcom:inoculateit:6.0:*:*:*:*:*:*:*

More vulnerabilities in Broadcom Inoculateit

CVE-2005-1693 — Critical (CVSS 10.0): Integer overflow in Computer Associates Vet Antivirus library, as used by CA InoculateIT 6.0, eTrust Antivirus r6.0…
CVE-2004-0937 — High (CVSS 7.5): Sophos Anti-Virus before 3.87.0, and Sophos Anti-Virus for Windows 95, 98, and Me before 3.88.0, allows remote…
CVE-2004-0935 — High (CVSS 7.5): Eset Anti-Virus before 1.020 (16th September 2004) allows remote attackers to bypass antivirus protection via a…
CVE-2004-0934 — High (CVSS 7.5): Kaspersky 3.x to 4.x allows remote attackers to bypass antivirus protection via a compressed file with both local and…
CVE-2004-0936 — High (CVSS 7.5): RAV antivirus allows remote attackers to bypass antivirus protection via a compressed file with both local and global…
CVE-2004-0933 — High (CVSS 7.5): Computer Associates (CA) InoculateIT 6.0, eTrust Antivirus r6.0 through r7.1, eTrust Antivirus for the Gateway r7.0 and…

All CVEs affecting Broadcom Inoculateit →